Issue 9, 2021

Retraction: Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217

Abstract

Retraction of ‘Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217’ by Jing Wang et al., RSC Adv., 2019, 9, 25232–25239, DOI: 10.1039/C9RA04500G.

Associated articles

Article information

Article type
Retraction
Submitted
18 Jan 2021
Accepted
18 Jan 2021
First published
26 Jan 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 5001-5001

Retraction: Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217

L. Fisher, RSC Adv., 2021, 11, 5001 DOI: 10.1039/D1RA90031E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements